SunWay Biotech Co., Ltd.
1271
Rank in Stocks
#19408
SunWay Biotech Co., LTD. dedicates itself to specialized research and... SunWay Biotech Co., LTD. dedicates itself to specialized research and development, coupled with the production and processing of technical materials. The company's primary focus involves the creation and manufacturing of specific bioproducts, including Monascus purpureus NTU 568 and Lactobacillus paracasei subsp. paracasei NTU 101, along with related offerings. Established in 2007, the firm operates from its headquarters in Taipei, Taiwan.
Share Price
$1.79
Last synced: 2026-11-10
Market Cap
$107.34M
Change (1 day)
4.64%
Change (1 year)
-14.16%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade SunWay Biotech Co., Ltd. (1271)
Category
Consumer Defensive
Operating Margin for SunWay Biotech Co., Ltd. (1271)
Operating Margin as of November 2026 TTM: 6.27%
According to SunWay Biotech Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 6.27%. At the end of 2025 the company had an operating margin of 10.48%.
Operating Margin history for SunWay Biotech Co., Ltd. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 6.27% | -40.17% |
| 2025 | 10.48% | -27.87% |
| 2024 | 14.53% | 58.28% |
| 2023 | 9.18% | -0.43% |
| 2022 | 9.22% | -79.09% |
| 2021 | 44.09% | 10.14% |
| 2020 | 40.03% | 63.72% |
| 2019 | 24.45% | -232.45% |
| 2018 | -18.46% | -77.13% |
| 2017 | -80.72% | 3.24% |
| 2016 | -78.19% | -49.31% |
| 2015 | -154.26% | -69.35% |
| 2014 | -503.30% | 47.77% |
| 2013 | -340.60% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 14.06% | -97.76% |
CH
|
|
| 11.72% | -98.13% |
FR
|
|
| 5.67% | -99.10% |
BR
|
|
| 9.43% | -98.50% |
CN
|
|
| 26.85% | -95.72% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SunWay Biotech Co., Ltd.'s operating margin
What is SunWay Biotech Co., Ltd.'s operating margin?
SunWay Biotech Co., Ltd.'s operating margin is 6.27%, as of Nov 2026.
What was SunWay Biotech Co., Ltd.'s operating margin in 2025?
In 2025, SunWay Biotech Co., Ltd.'s operating margin was 10.48%, compared with 14.53% in 2024.
How has SunWay Biotech Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, SunWay Biotech Co., Ltd.'s operating margin was highest in 2021 (44.09%) and lowest in 2023 (9.18%).
How does SunWay Biotech Co., Ltd.'s operating margin compare with similar companies?
SunWay Biotech Co., Ltd.'s operating margin (6.27%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Foshan Haitian Flavouring and Food Company Ltd., with 26.85%.